A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults

Study identifier:FM025

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Post-Marketing Evaluation of the Safety of Influenza Virus Vaccine Live, Intranasal (FluMist) in Healthy Children and Healthy Adults 5-49 Years of Age

Medical condition

Healthy

Phase

-

Healthy volunteers

Yes

Study drug

-

Sex

All

Actual Enrollment

63061

Study type

Observational

Age

5 Years - 49 Years

Date

Study Start Date: 01 Oct 2003
Primary Completion Date: 01 Sept 2008
Study Completion Date: 01 Jun 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2012 by MedImmune, LLC

Sponsors

MedImmune, LLC

Collaborators

N/A

Inclusion and exclusion criteria